HomeAIDX • NASDAQ
add
20/20 Biolabs Inc
Previous close
$1.88
Day range
$1.71 - $1.91
Year range
$1.51 - $50.00
Avg Volume
402.09K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 538.27K | 0.41% |
Operating expense | 1.04M | -25.85% |
Net income | -1.31M | -4.70% |
Net profit margin | -242.96 | -4.28% |
Earnings per share | — | — |
EBITDA | -892.71K | 26.31% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.03M | -42.49% |
Total assets | 4.14M | 15.43% |
Total liabilities | 4.16M | 99.94% |
Total equity | -19.22K | — |
Shares outstanding | 10.44M | — |
Price to book | -188.00 | — |
Return on assets | -61.87% | — |
Return on capital | -175.03% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.31M | -4.70% |
Cash from operations | -511.67K | 4.62% |
Cash from investing | — | — |
Cash from financing | 392.80K | 257.01% |
Net change in cash | -118.87K | 72.12% |
Free cash flow | -549.96K | — |
About
Founded
2000
Headquarters
Website
Employees
19
